A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome
NCT05875233 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2024-07-24
Summary
This is a virtual, open-label, 2-armed study that will last 6 months. All participants will take the supplements daily and complete questionnaires at baseline and at the end of weeks 4, 8, 12, 16, 20, and 24 (study may be concluded at week 20 if results are seen earlier). The study will involve 70 participants with polycystic ovary syndrome (PCOS), 35 who are on hormonal birth control, and 35 who are not.
A subgroup of 20 participants from the non-birth control group, who experience hormonal acne/frequent hormonal breakouts will provide photographs of the face for expert skin grading at baseline, week 12, week 20, and week 24 (if the study is continued until week 24).
Questionnaires will be used to monitor changes in the menstrual cycle (regularity, frequency, predictability), bloating, fluid retention, weight gain, mood (mood swings, anxiety, mental clarity/focus, brain fog), pain, fatigue, acne, facial/bodily hair, and sleep quality. Expert skin grading will be carried out by a dermatologist to monitor changes in acne and skin clarity indicative of systemic effects of androgen excess. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores.
Conditions
- Polycystic Ovary Syndrome
Interventions
- OTHER
-
Elix Daily Harmony
Elix Daily Harmony is a clinical-strength, organic blend of hormone-balancing Traditional Chinese Medicine (TCM) herbs and adaptogens. Contains Angelica Sinensis, licorice, ginger, Bupleurum, Cyperus Rotundus, White Peony, Mint, Poria, Atractylodes, White Ginseng, Reishi, Rehmannia Root, and Astragalus. Participants should add 3 droppers full (half a teaspoon or 2.5 ml) of Elix Daily Harmony to their tea or other warm or room temperature beverage each morning, 1-2 hours after their first meal. The product should not be taken with iced drinks or with food.
- OTHER
-
Elix Cycle Balance
A tailored blend of medicinal herbs to holistically support menstrual symptoms by treating underlying imbalances. Participants should take 3 droppers full (half a teaspoon or 2.5 ml) of Elix Cycle Balance daily before bed with tea or other warm or room temperature beverage. The product should not be taken with iced drinks or with food.
Sponsors & Collaborators
-
Citruslabs
collaborator INDUSTRY -
Zenchi, Inc.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 36 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-13
- Primary Completion
- 2024-08-30
- Completion
- 2024-08-30
Countries
- United States
Study Locations
More Related Trials
-
Plant Exosomes and Patients Diagnosed With Polycystic Ovary Syndrome (PCOS) 17
NCT03493984 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of the Mediterranean Diet and Synbiotics in Polycystic Ovary Syndrome
NCT07342946 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Changes in Hormonal Profile and Body Mass Index in Women With Polycystic Ovary Syndrome After Probiotic Intake
NCT06761625 ·Status: COMPLETED ·Phase: NA
-
Combined Oral Contraceptive Pill and Resistance Starch
NCT06852365 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Exercise on Cardiometabolic Profile in Women With Polycystic Ovary Syndrome
NCT03678714 ·Status: COMPLETED ·Phase: NA
-
Effect of Dietary Modifacation on Microbiota in Overweight and Obese Polycystic Ovary Syndrome Patients
NCT03325023 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.
NCT06551285 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
NCT01733459 ·Status: COMPLETED ·Phase: PHASE3
-
The Gut Microbiome in Women With Polycystic Ovary Syndrome
NCT03642600 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
NCT05370521 ·Status: TERMINATED ·Phase: PHASE2
-
Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
NCT02651636 ·Status: COMPLETED ·Phase: NA
-
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342 ·Status: UNKNOWN
-
Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome
NCT01788215 ·Status: COMPLETED ·Phase: PHASE3
-
Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
NCT00365638 ·Status: COMPLETED ·Phase: NA
-
Effects of Alpha-acid Lipoic in PCOS Women
NCT02666170 ·Status: UNKNOWN ·Phase: NA
-
Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome
NCT05246865 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome
NCT01859663 ·Status: COMPLETED
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN
-
Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
NCT01360996 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
NCT00989781 ·Status: COMPLETED ·Phase: NA
-
Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS
NCT03717935 ·Status: COMPLETED ·Phase: NA
-
Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary Syndrome
NCT06968455 ·Status: COMPLETED
-
Polycystic Ovary Syndrome and Exercise
NCT03362918 ·Status: COMPLETED ·Phase: NA
-
An Integrated Self-Management Intervention for Adolescents With Polycystic Ovary Syndrome
NCT03600337 ·Status: COMPLETED ·Phase: NA
-
The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2
NCT05647356 ·Status: UNKNOWN ·Phase: NA